Technology
A Japanese Microalgae Technology Investigated From Mechanism to Production
The scientific foundation of the technology extends beyond production observations. Research has investigated its composition, glycolipid fractions, biological activity, metabolic pathways and responses in cellular, animal and human studies.
- Discovery
- Microalgal composition
- Functional glycolipids
- Biological mechanisms
- Peer-reviewed research
- Production validation
01 · Discovery
Discovered in Japan
The microalga was identified in a Japanese hot-spring environment and has been studied in Japan over many years, first in research settings and then in production.
02 · Microalgal composition
What the material contains
Research has characterised the material's composition, including its lipid and glycolipid fractions, as a basis for investigating its biological activity.
03 · Functional glycolipids
A Distinctive Glycolipid Profile
Analytical comparisons indicate a distinctive lipid and glycolipid composition, including digalactosyldiacylglycerol (DGDG). DGDG and other glycolipid fractions have been investigated in experimental research for their potential biological activity.
The contribution, absorption and biological effects of individual components remain areas of ongoing research.
04 · Biological mechanisms
Investigating Biological Pathways
- Microalgal components
- Cellular and metabolic pathways
- Oxidative stress / inflammatory signaling
- Physiological response
Peer-reviewed research has investigated pathways including the AGE–RAGE–oxidative stress axis, inflammatory signaling, adipocyte biology and metabolic regulation.
These findings provide mechanistic context but should not be interpreted as evidence of disease treatment.
05 · Peer-reviewed human research
Investigated in a Randomized Human Study
12 WEEKS
- Randomized
- Double-blind
- Placebo-controlled
- 29 participants completed
A peer-reviewed study published in Pharmacological Research examined oral intake of the spa-derived microalgal material in apparently healthy, overweight Japanese adults.
Compared with placebo, the study reported statistically significant differences in several baseline-adjusted metabolic parameters, including fasting plasma glucose, fasting insulin, HOMA-IR and diastolic blood pressure.
The participants were overweight, non-diabetic Japanese adults. The study was small, and the authors noted that the findings should not automatically be generalized to other populations. Human research is not evidence for livestock or aquaculture outcomes.
Kasada K. et al. · Pharmacological Research 152 (2020) 104633 · DOI: 10.1016/j.phrs.2020.104633
View Research Record06 · Production validation
From Japanese evidence to local data
Field observations across aquaculture, poultry and livestock show what has been explored in production. They are not clinical proof. The next step is always validation under your own species, system and conditions.
- 01
Evidence in Japan
- 02
Validate locally
- 03
Generate local data
- 04
Optimize
- 05
Scale
MEGUMI BIO does not present the technology as a medicine or disease treatment. Regulatory classification and permitted claims depend on the intended use and jurisdiction.